<DOC>
	<DOCNO>NCT00505648</DOCNO>
	<brief_summary>Efficacy tolerance Tegeline® treatment hypersensitivity syndrome . Immunological study T cell index phenotype functionality hypersensitivity syndrome .</brief_summary>
	<brief_title>Treatment Hypersensitivity Syndrome ( DRESS ) With Tegeline® ( Human Immunoglobulin )</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity Syndrome</mesh_term>
	<criteria>Age &gt; = 18 Cutaneous and/or mucous eruption Polyadenopathy Body temperature &gt; 38°C Hematology disorder : Hypereosinophily &gt; 1.5 G/l , lymphocytosis &gt; 5G/l , atypical blood lymphocyte Consent obtain patient Age &lt; 18 No consent obtain patient IgV allergy Dress sérious visceral attack vital diagnostic ( sharp cardiac insufficiency , sharp respiratory insufficiency , hepatic insufficiency , sharp renal insufficiency ) Oral therapy immunosuppressive therapy ( Methotrexate , cyclosporine , cyclophosphamide , etc . ) IgA deficiency , MCI &gt; =35 Sharp renal insufficiency Dress creatinaemia &lt; 60 ml/min ( Cockroft )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hypersensitivity</keyword>
	<keyword>Syndrome</keyword>
	<keyword>Tegeline</keyword>
</DOC>